Weight and Body Mass Index Change After Switching to Integrase Inhibitors or Tenofovir Alafenamide Among Women Living with HIV

Weight and body mass index (BMI) change was assessed among women after switch to integrase inhibitors (INSTIs) and/or tenofovir alafenamide (TAF). From 2006 to 2019, 1,458 women living with HIV enrolled in the Women's Interagency HIV Study and on antiretroviral therapy (ART) with ≥1 study visit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:AIDS Res Hum Retroviruses
Asıl Yazarlar: Lahiri, Cecile D., Xu, Yanxun, Wang, Kunbo, Alvarez, Jessica A., Sheth, Anandi N., O'Halloran, Jane, Spence, Amanda B., Tien, Phyllis, Gustafson, Deborah R., Milam, Joel, Fischl, Margaret A., Konkle-Parker, Deborah, Adimora, Adaora A., Sharma, Anjali, Weber, Kathleen M., Ofotokun, Igho, Rubin, Leah H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Mary Ann Liebert, Inc., publishers 2021
Konular:
Epidemiology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8213005/
https://ncbi.nlm.nih.gov/pubmed/33231474
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2020.0197
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller